Cyclerion Therapeutics (CYCN) Net Income towards Common Stockholders Growth (1y) (2019 - 2023)
Cyclerion Therapeutics (CYCN) Net Income towards Common Stockholders Growth (1y) (2019 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-58.11% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
104.24% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
-129.68% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Cyclerion Therapeutics |
11.94 Mn |
8.70 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2023 |
321.28% |
| Jun 30, 2023 |
82.30% |
| Mar 31, 2023 |
70.99% |
| Dec 31, 2022 |
79.82% |
| Sep 30, 2022 |
46.04% |
| Jun 30, 2022 |
16.96% |
| Mar 31, 2022 |
3.07% |
| Dec 31, 2021 |
25.43% |
| Sep 30, 2021 |
47.96% |
| Jun 30, 2021 |
17.19% |
| Mar 31, 2021 |
33.78% |
| Dec 31, 2020 |
26.20% |
| Sep 30, 2020 |
20.61% |
| Jun 30, 2020 |
39.44% |
| Mar 31, 2020 |
45.89% |
| Dec 31, 2019 |
15.69% |
| Sep 30, 2019 |
6.72% |
| Jun 30, 2019 |
-8.30% |
| Mar 31, 2019 |
-47.85% |
